Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01470274 |
Recruitment Status
:
Completed
First Posted
: November 11, 2011
Last Update Posted
: July 29, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cardiovascular Disease Chronic Obstructive Pulmonary Disease |
Study Type : | Observational |
Actual Enrollment : | 18 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Safety of the CO-rebreathing Method in Stable Coronary Artery Disease and COPD Patients |
Study Start Date : | November 2011 |
Actual Primary Completion Date : | January 2012 |
Actual Study Completion Date : | February 2012 |


Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Stable coronary artery disease
- Stable COPD
- Optimal medication
Exclusion Criteria:
- Unstable disease
- co-morbidities

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01470274
Norway | |
Norwegian University of Science and Technology | |
Trondheim, Norway, 7489 |
Principal Investigator: | Trine Karlsen, PhD | Norwegian University of Science and Technology |
Publications of Results:
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT01470274 History of Changes |
Other Study ID Numbers: |
2011/1792 |
First Posted: | November 11, 2011 Key Record Dates |
Last Update Posted: | July 29, 2016 |
Last Verified: | July 2016 |
Keywords provided by Norwegian University of Science and Technology:
Blood volume CO-rebreathing COPD CVD |
Additional relevant MeSH terms:
Lung Diseases Cardiovascular Diseases Coronary Artery Disease Myocardial Ischemia Coronary Disease Lung Diseases, Obstructive |
Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Heart Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |